1[1]Seger A,Mekori YA.The Cardiac Insufficiency Bisoprolol Study Ⅱ[J].Lancet,1999,353(9161):1361.
2[2]MERIT-HF Study Group.Effect of metoprolol CB/XL in chronic heart faiure:Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure(MERIT-HF)[J].Lancet,1999,353(9169):2001-2007.
3[3]Packer M,Coats AJ,Fowler MB,et al.Effect of carvedilol on survival in severe chronic heart failure[J].Engl J Med,2001,344(22):1651-1658.
4[6]Wikstrand J,Hjalmarson A,Waagstein F,et al.Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure:analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure(MERIT-HF)[J].J Am Coll Cardiol,2002,40(3):491-498.
5[7]Simon T,Mary-Krause M,Funck-Brentano C,et al.Bisoprolol dose-response relationship in patients with congesyive heart failure:a subgpoup analysis in the cardiac insufficiency bisoprolol study(CIBIS Ⅱ)[J].Eur Heart J,2003,24(6):552-559.
6[8]Dargie HJ.Betablockers in heart failure[J].Lancet,2003,362(9377):2-3.
71.Packer M,Bristow M R,Cohn I N,et al.Effect of carvedilol on morbidity and mortality in chronic heart failure.N Engl J Med,1996,334:1349-1355.
8CIBIS-Ⅱ investigators and committees.The cardiac insufficiency bisoprolol study Ⅱ(CIBIS Ⅱ) a randomized trial.Lancet,1999,353(9146): 9-13.
9MERIT-HF study group.Effect of metoprolo CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF).Lancet,1999,353: 2001-2007.
10Bristow M R.Mechanism of action of beta-blocking agents in heart failure.Am J Cardiol,1997,80(11A):26L-40L.
